Korean Circ J.  2010 Oct;40(10):527-529. 10.4070/kcj.2010.40.10.527.

Successful Percutaneous Coronary Intervention for Acute Coronary Syndrome in a Patient With Severe Hemophilia A

  • 1Division of Cardiology, Department of Internal Medicine, Inje University College of Medicine, Busan Paik Hospital, Busan, Korea. jo1216@chollian.net
  • 2Division of Cardiology, Department of Internal Medicine, Ulsan Hospital, Ulsan, Korea.
  • 3Division of Cardiology, Department of Internal Medicine, Changwon Fatima Hospital, Changwon, Korea.


Patients with hemophilia generally have a reduced frequency of coronary artery disease compared to the general population. As advances in the management of hemophilia have increased their life expectancy, the prevalence of coronary artery disease also has increased. However, there are no standard treatment guidelines for coronary artery disease in patients with hemophilia, especially in the field of coronary intervention. We report the case of a patient with severe hemophilia A who presented with acute coronary syndrome and was successfully treated with percutaneous coronary intervention.


Hemophilia A; Percutaneous transluminal angioplasty; Acute Coronary Syndrome

MeSH Terms

Acute Coronary Syndrome
Coronary Artery Disease
Hemophilia A
Life Expectancy
Percutaneous Coronary Intervention


  • Fig. 1 Initial coronary angiography. Coronary angiography reveals focal luminal narrowing at the proximal and mid segments of the left anterior descending artery (A). Bare-metal stent (Vision®, Abbott Inc, Santa Clara, CA, USA) was successfully implanted at the proximal lesion (B).

  • Fig. 2 Follow-up coronary angiography 10 months after the initial procedure. Coronary angiography showed 70% in-stent restenosis at the proximal left anterior descending artery (arrows). However, the patient was asymptomatic but managed with medical therapy.


1. Plug I, van der Born JG, Peters M, et al. Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. J Thromb Haemost. 2006. 4:510–516.
2. Rosendaal FR, Briet E, Stibbe J, et al. Haemophilia protects against ischaemic heart disease: a study of risk factors. Br J Haematol. 1990. 75:525–530.
3. Srámek A, Kriek M, Rosendaal FR. Decreased mortality of ischaemic heart disease among carriers of haemophilia. Lancet. 2003. 362:351–354.
4. Srámek A, Reiber JH, Gerrits WB, Rosendaal FR. Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendency. Circulation. 2001. 104:762–767.
5. Girolami A, Ruzzon E, Fabris F, Varvarikis C, Sartori R, Girolami B. Myocardial infarction and other arterial occlusions in hemophilia a patients. a cardiological evaluation of all 42 cases reported in the literature. Acta Haematol. 2006. 116:120–125.
6. Bond L, Bevan D. Myocardial infarction in a patient with hemophilia treated with DDAVP. N Engl J Med. 1988. 318:121.
7. Arora U, Dhir M, Cintron G, Strom JA. Successful multi-vessel percutaneous coronary intervention with bivalirudin in a patient with severe hemophilia A: a case report and review of literature. J Invasive Cardiol. 2004. 16:330–332.
8. Krolick MA. Successful percutaneous coronary intervention in a patient with severe haemophilia A using bivalirudin as the sole procedural anticoagulant. Haemophilia. 2005. 11:415–417.
9. Park DW, Park SW. Stent thrombosis in the era of the drug-eluting stent. Korean Circ J. 2005. 35:791–794.
10. Brener SJ, Steinhubl SR, Berger PB, Brennan DM, Topol EJ. Prolonged dual antiplatelet therapy after percutaneous coronary intervention reduces ischemic events without affecting the need for repeat revascularization: insights from the CREDO trial. J Invasive Cardiol. 2007. 19:287–290.
11. Bovenzi F, De Luca L, Signore N, Fusco F, de Luca I. Abciximab for the treatment of an acute thrombotic coronary occlusion during stent implantation in a patient with severe hemophilia B. Ital Heart J. 2003. 4:728–730.
12. MacKinlay N, Taper J, Renisson F, Rickard K. Cardiac surgery and catheterization in patients with haemophilia. Haemophilia. 2000. 6:84–88.
13. Ferrario C, Renders F, Cairoli A, Vuffray A, Spertini O, Angelillo-Scherrer A. Management of an acute coronary syndrome in a patient tvv with severe haemophilia A. Haemophilia. 2007. 13:763–765.
Full Text Links
  • KCJ
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr